Oaktree Acquisition Corp. III Life Sciences (OACC)

NASDAQ: OACC · Real-Time Price · USD
10.45
+0.01 (0.10%)
May 30, 2025, 4:00 PM - Market closed
Market Cap 256.89M
Revenue (ttm) n/a
Net Income (ttm) 2.66M
Shares Out 24.58M
EPS (ttm) n/a
PE Ratio 96.45
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,220
Open 10.45
Previous Close 10.44
Day's Range 10.45 - 10.45
52-Week Range 9.95 - 10.85
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About OACC

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Oct 24, 2024
Country United States
Stock Exchange NASDAQ
Ticker Symbol OACC
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering

Oaktree Acquisition Corp. III Life Sciences, a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities...

7 months ago - Business Wire

SPAC Oaktree Acquisition III Life Sciences files for a $175 million IPO, formed by Oaktree Capital Management

Oaktree Acquisition III Life Sciences, a blank check company formed by Oaktree Capital targeting healthcare businesses, filed on Friday with the SEC to raise up to $175 million in an initial public of...

8 months ago - Renaissance Capital

Oaktree Acquisition Corp. III Life Sciences IPO Registration Document (S-1)

Oaktree Acquisition Corp. III Life Sciences has filed to go public with an IPO on the NASDAQ.

8 months ago - SEC